All News

Article

Best Interventions for Gout Flares

Jack Cush, MD May 31, 2021

A recent metanalysis assessed the comparative efficacy of current first-line pharmacologic antiinflammatory interventions for gout flares and surmised that canakinumab and intravenous or intramuscular corticosteroids are superior to nonsteroidal antiinflammatory drugs [NSAIDs].

Article

COLCORONA: Protective Effect of Colchicine in COVID-19

Jack Cush, MD May 31, 2021

Lancet Respiratory Medicine has reported the results of the COLCORONA trial, showing that in patients with PCR-confirmed COVID-19 infection, colchicine led to a significantly lower rate of death or hospital admission from COVID.

RNL 2021 - ACR COVID Vaccine Guidance: Dr. Jeff Curtis https://t.co/nJgbwB1RdA https://t.co/0Jir2vtaFH

https://bit.ly/3i9GpwT

Hands-Down Rheumatology - Sarcoidosis usually presents as a monarthritis or oligoarthritis. Late sarcoid arthritis affects knees, ankles, fingers (dactylitis). Bony lesions show honeycomb trabecular pattern). https://t.co/lmXBbJz6ts

https://bit.ly/3uHkT5l

Top May Tweet: Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w

https://bit.ly/3ekjKM7

Hands-Down Rheumatology - Mechanics hands - rough, thickened/caloused, cracks/fissures; seen in 20-70% of dermatomyositis; associated with the anti-synthetase syndrome, but also w/ lung dz and amyopathic DM https://t.co/bkCI3SUXNh https://t.co/jrOGkKAm9z

Hands-Down Rheumatology - Swollen Hands In Rheumatoid Arthritis - could be from synovitis, tenosynovitis, edema, effusion, bony hypertrophy, nodules, secondary OA. https://t.co/dRCMzgdHqf

https://bit.ly/3uD4iQi

Hands-Down Rheumatology - Erosive hand osteoarthritis (EHOA) affects 2.6% of knee OA pts (from Osteoarthritis Initiative) Risk factors - older [RR 0.76), female (RR=1.73), greater OA severity, and "thinner bones" https://t.co/3s8E4F6QDR

https://bit.ly/3hClbYl

News: Triple DMARD Therapy Bested by Biologics in Swedish Registry The Swedish Register compared outcomes of 1502 RA patients initiating either biologics plus MTX or triple therapy and showed similar rates of sustained remission. https://t.co/7JJxGF1tHz https://t.co/ht6kAsJkb9

https://bit.ly/3uwbPjK

RheumNow Podcast – Heart, Lung & Liver (5.28.2021) Dr Jack Cush reviews the news and journal reports from this past week on RheumNow. https://t.co/a9fvgaJVnQ https://t.co/r3nbf2Ftdb

https://bit.ly/3hYI9Jq

News: EULAR Guidelines on Intraarticular Therapy EULAR has published evidence-based recommendations on the use of intra-articular therapies (IAT) based on the literature review and recommendations of a multidisciplinary international task force. https://t.co/Z6vC0x9zY1 https://t.co/gVCWMIJxtu

https://bit.ly/3covoo7

Study of National inpatient sample database (2015 to 2017) showed the frequency of atrial fibrillation in rheumatic disease (RD) pts finding that AF frequency highest in gout followed by vasculitis, and PMR. RD Mortality was 2 fold higher with AF. https://t.co/enno6hrKOI

https://bit.ly/2SHh4jx

A trial of sarilumab in 431 hospitalized COVID-19 patients on supplemental oxygen, Compared to placebo, sarilumab did not improve COVID outcomes https://t.co/postv1eK3F

https://bit.ly/34pRMsz

Kidney biopsies in patients with lupus – how early and how often? Dr. Fogo and Dr.Hogan explain why a kidney biopsy is critical for diagnosis and characterization of kidney involvement by SLE #SLEEducatorsNetwork. Sponsored by GSK US Medical Affairs https://t.co/ta3hliB9ls https://t.co/hJE6BNlNqk

https://bit.ly/34cs370

Pirfenidone, studied in 127 pts w/ CVD/CTD ILD, fibrotic interstitial pneumonia, chr hypersensitivity pneumonitis, & asbestoslung fibrosis. Pirefenidone had significantly less FVC% decline compared with placebo (p=0·043) https://t.co/H1s6ut4NhG

https://bit.ly/2RLVx9g

Dr. Samir V. Parikh from the #SLEEducatorsNetwork discusses the major treatment goals for lupus nephritis and the broader needs of the patient in this program- Defining Treatment Goals for Lupus Nephritis. Sponsored by GSK US Medical Affairs https://t.co/f2Y707H2kR https://t.co/4xMIBp2yEh

https://bit.ly/34d6qDD

RNL 2021: Treatment Advances in SpA: Dr. Nigil Haroon Dr. Nigil Haroon presents Treatment Advances in SpA at RheumNow Live 2021. https://t.co/9ZA0loThx6

https://bit.ly/3uu465G

News: Methotrexate Impairs COVID Vax Response https://t.co/M9d31UAxb7

https://bit.ly/3oVt6li

New podcast up! Download wherever podcasts are available. https://t.co/y95zS04pqw

https://bit.ly/3c10mSW

News: Efficacy of 6 Weeks Antibiotics with Prosthetic Joint Infections https://t.co/mSDEIKUL1h

https://bit.ly/34rZFOq

Topics

All News

Best Interventions for Gout Flares

COLCORONA: Protective Effect of Colchicine in COVID-19

Do you get our email newsletter?